GILDER GAGNON HOWE & CO LLC

Position in SANA — Sana Biotechnology, Inc.

CIK 902464 New York, NY

Position in SANA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$313,960

+$38,068 QoQ

Shares Held

89,960

-6.1% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#73

of 211 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GILDER GAGNON HOWE & CO LLC holds $353,222,516 across 21 Biotechnology names. SANA ranks #21 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	269,051	$80,992,422
2	NKTR	Nektar Therapeutics	600,873	$41,946,944
3	BBIO	BridgeBio Pharma, Inc.	548,926	$40,884,008
4	ARQT	Arcutis Biotherapeutics, Inc.	1,313,211	$34,432,392
5	CYTK	Cytokinetics Inc	400,245	$34,096,871
6	KYMR	Kymera Therapeutics, Inc.	229,053	$26,265,507
7	QURE	uniQure N.V.	530,979	$24,456,892
8	MDGL	Madrigal Pharmaceuticals, Inc.	28,573	$15,342,272

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$313,960	89,960	-6.1%	Shares	Sole	2026-08-14
2026-03-31	$275,892	95,796	+1.8%	Shares	Sole	2026-05-15
2025-12-31	$382,873	94,072	+2.8%	Shares	Sole	2026-02-17
2025-09-30	$324,963	91,539	+32.1%	Shares	Sole	2025-11-14
2024-09-30	$288,250	69,291	-17.8%	Shares	Sole	2024-11-14
2024-03-31	$842,590	84,259	+0.6%	Shares	Sole	2024-05-15
2022-03-31	$691,981	83,775	-79.2%	Shares	Defined	2022-05-16
2021-09-30	$9,074,681	402,961	+0.1%	Shares	Defined	2021-11-15
2021-06-30	$7,911,557	402,419	-57.3%	Shares	Defined	2021-08-16
2021-03-31	$31,525,192	941,894	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.